X0202 SCHEDULE 13G 0001957912 XXXXXXXX LIVE Common Stock, par value $0.001 per share 03/30/2026 0000025743 TherapeuticsMD, Inc. 88338N206 951 Yamato Road, Suite 220 Boca Raton FL 33431 Rule 13d-1(c) Baselake Partners, LP b DE 0.00 607181.00 0.00 607181.00 607181.00 N 5.2 PN Please see note in Item 4(a) Baselake Management, LLC b DE 0.00 607181.00 0.00 607181.00 607181.00 N 5.2 IA OO Please see note in Item 4(a) David Paolella b X1 0.00 607181.00 0.00 607181.00 607181.00 N 5.2 HC IN Please see note in Item 4(a) TherapeuticsMD, Inc. 951 Yamato Road, Suite 220 Boca Raton, Florida 33431 Baselake Partners, LP* Baselake Management, LLC* David Paolella* 3155 W. Big Beaver Road, Suite 207, Troy, Michigan 48084 Baselake Partners, LP - Delaware Baselake Management, LLC - Delaware David Paolella - United States of America Y Baselake Partners, LP - 607,181* Baselake Management, LLC - 607,181* David Paolella - 607,181* The Common Stock (the "Shares") reported as of the filing date are held by Baselake Partners, LP (the "Fund"). Baselake Management, LLC serves as the investment manager to the Fund (the "Investment Manager"). David Paolella serves as the managing member of the Investment Manager (the "Managing Member," and collectively with the Fund and the Investment Manager, the "Reporting Persons"). By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the Shares owned directly by the Fund. The percentages reported herein are calculated based upon a statement in the Issuer's 10-K, indicating that there are 11,574,362 Shares issued and outstanding as of March 30, 2026. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the Shares for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of the Reporting Persons pecuniary interest therein. Baselake Partners, LP - 5.2%* Baselake Management, LLC - 5.2%* David Paolella - 5.2%* Baselake Partners, LP - 0 Baselake Management, LLC - 0 David Paolella - 0 Baselake Partners, LP - 607,181* Baselake Management, LLC - 607,181* David Paolella - 607,181* Baselake Partners, LP - 0 Baselake Management, LLC - 0 David Paolella - 0 Baselake Partners, LP - 607,181* Baselake Management, LLC - 607,181* David Paolella - 607,181* Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Baselake Partners, LP /s/ David Paolella 04/06/2026 Baselake Management, LLC /s/ David Paolella 04/06/2026 David Paolella /s/ David Paolella 04/06/2026 Exhibit I - JOINT FILING STATEMENT